Delivery Order SPE2DB20D3103-SPE2DB23FP0D7
Award Date
7/17/23
Potential Completion Date
7/18/23
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML. The contract is a Firm Fixed Price Delivery Order valued at $7,214.20 and has an ultimate completion date of August 2, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,096,500 units of the pharmaceutical product GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML. The contract has a firm fixed price of $8,824.41 and a completion date of July 10, 2024. This is a delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,698.53 firm fixed-price delivery order is for the supply of Granix 300 mcg TBO, a specialty medication. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, issued by the Defense Logistics Agency (DLA), is for the delivery of 4565153322 GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML pharmaceutical products. The firm-fixed-price delivery order, valued at $2,070.44, has a period of performance through July 16, 2024. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite...
This contract award to Amerisourcebergen Drug Corp. (Corporate Office Division) was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GRANIX 300 MCG/ML VIALML, a pharmaceutical product. The $2,462.88 firm-fixed-price contract has an ultimate completion date of August 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical for a comprehensive range...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEVH0, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of GRANIX 300 MCG/ML VIALML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,231.44 and an ultimate completion date of June 5, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $1,213.62 to Amerisourcebergen Drug Corporation for 4562185573 GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML. Performance will occur in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order is associated with the Defense Logistics Agency's medical supply chain and will provide Granix, a medication used to treat neutropenia. Amerisourcebergen Corporation is the...
This federal contract award, with an ID of SPE2DX15D3006|SPE2DX24F03TQ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,598.70, is a delivery order for the supply of Granisetron HCl 1 mg tablets. It is a firm fixed-price contract with a completion date of July 2, 2024. The contract does not have any set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,790.07, is for the delivery of 4567631605 - Granisetron HCl 1 mg Tablet UD 20s. The contract has an ultimate completion date of March 20, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $3,122.21 for the supply of GRALISE ER 300 MG TABLET 90S. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 26, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a...